Showing 41-45 of 45 for: Essential Evidence Topics > Gynecologic
- Urethritis (female)
Essential Evidence Topics, 29-Jul-2022
Overall Bottom Line: The United States Preventive Services Task Force (USPSTF, 2021) recommends screening for chlamydia in all sexually-active nonpregnant women 24 years and younger and older women who are at increased risk. In addition, all pregnant wo
- Uterine cancer
Essential Evidence Topics, 22-Mar-2021
Overall Bottom Line: All women with postmenopausal bleeding or older than 35 years with abnormal uterine bleeding should be evaluated for endometrial cancer. Either endometrial biopsy or transvaginal ultrasound (TVUS) is appropriate diagnostic option.
- Uterine leiomyoma
Essential Evidence Topics, 27-Mar-2023
Overall Bottom Line: Consider fibroids in women reporting pelvic pain and abnormal uterine bleeding (AUB), although the strength of the association between myomas and these symptoms is questionable. Of medical treatment options, the levonorgestrel intra
- Vaginal and vulvar malignancy
Essential Evidence Topics, 22-Mar-2021
Overall Bottom Line: Vaginal and vulvar malignancies are quite rare, so screening asymptomatic women is not cost effective. The earliest possible diagnosis requires the clinician to proceed quickly to biopsy of suspicious lesions. Vulvar intraepitheli
- Vaginitis
Essential Evidence Topics, 26-Dec-2022
Overall Bottom Line: Microscopy of the vaginal discharge should be used to determine an etiology for vaginitis. The American College of Obstetricians and Gynecologists (ACOG) guidelines (2020) recommend use of Amsel clinical criteria or Gram stain with Nu